Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03506386 · OUTCOME

Number of Multiple Myeloma (MM) Participants Categorized by Treatment Patterns

Multiple Myeloma (MM) Profile in Brazil: A Retrospective Observational Analysis · Source last updated 2021-02-08

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
From initial diagnosis up to end of follow up treatment or to the retrospective cut-off date within the time of interest (between January 1, 2008, and December 31, 2016) [approximately 11.7 years]

What was measured

Treatment patterns were collected from institutional charts \[included public institution, private institution and both (90% public and 10% private) institutions\] of participants in Brazil. The treatment patterns were collected as induction treatment, consolidation treatment, maintenance treatment performed at Baseline (at initial diagnosis) and as a induction treatment, maintenance treatment and type of treatment performed after transplantation, for second to tenth line of treatment. Only categories with data are reported. Participants were counted multiple times in different categories.

Analysis population: All participants eligible for analyses were included. Number analyzed are the number of participants with evaluable data for given category.

Groups in this outcome

Multiple Myeloma Participants

Participants with MM were observed retrospectively since the diagnosis up to death or lost to follow-up within the eligibility window of time (between January 1, 2008 and December 31, 2016), in this study.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants922

Reported measurements

Baseline: Induction Treatment Performed

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants916

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants394Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants456Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants66Not reportedNot reportedNot reportedNot reported
Baseline: Consolidation Treatment Performed

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants17

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants3Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants14Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants0Not reportedNot reportedNot reportedNot reported
Baseline: Maintenance Treatment Performed

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants76

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants39Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants32Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants5Not reportedNot reportedNot reportedNot reported
2nd Line: Induction Treatment Performed

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants495

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants230Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants236Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants29Not reportedNot reportedNot reportedNot reported
2nd Line: Maintenance Treatment Performed

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants35

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants22Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants9Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants4Not reportedNot reportedNot reportedNot reported
2nd Line: Type of Treatment Performed After Transplantation

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants14

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants7Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants6Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants1Not reportedNot reportedNot reportedNot reported
3rd Line: Induction Treatment Performed

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants284

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants142Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants131Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants11Not reportedNot reportedNot reportedNot reported
3rd Line: Maintenance Treatment Performed

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants18

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants13Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants3Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants2Not reportedNot reportedNot reportedNot reported
3rd Line: Type of Treatment Performed After Transplantation

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants3

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants2Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants1Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants0Not reportedNot reportedNot reportedNot reported
4th Line: Induction Treatment Performed

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants146

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants70Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants70Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants6Not reportedNot reportedNot reportedNot reported
4th Line: Maintenance Treatment Performed

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants6

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants3Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants2Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants1Not reportedNot reportedNot reportedNot reported
4th Line: Type of Treatment Performed After Transplantation

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants1

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants0Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants1Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants0Not reportedNot reportedNot reportedNot reported
5th Line: Induction Treatment Performed

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants78

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants38Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants37Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants3Not reportedNot reportedNot reportedNot reported
5th line: Maintenance Treatment Performed

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants3

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants1Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants2Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants0Not reportedNot reportedNot reportedNot reported
5th Line: Type of Treatment Performed After Transplantation

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants1

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants0Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants1Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants0Not reportedNot reportedNot reportedNot reported
6th Line: Induction Treatment Performed

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants41

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants21Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants19Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants1Not reportedNot reportedNot reportedNot reported
6th Line: Maintenance Treatment Performed

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants2

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants2Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants0Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants0Not reportedNot reportedNot reportedNot reported
7th Line: Induction Treatment Performed

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants16

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants6Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants10Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants0Not reportedNot reportedNot reportedNot reported
8th Line: Induction Treatment Performed

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants5

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants3Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants2Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants0Not reportedNot reportedNot reportedNot reported
9th Line: Induction Treatment Performed

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants3

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants1Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants2Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants0Not reportedNot reportedNot reportedNot reported
10th Line: Induction Treatment Performed

Analysis denominator · Participants

GroupSource count
Multiple Myeloma Participants2

Public Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants1Not reportedNot reportedNot reportedNot reported

Private Institution

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants1Not reportedNot reportedNot reportedNot reported

Both (90% public and 10% private) Institutions

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Multiple Myeloma Participants0Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        394
      title
      Public Institution
    2. measurements
      1. group Id
        OG000
        value
        456
      title
      Private Institution
    3. measurements
      1. group Id
        OG000
        value
        66
      title
      Both (90% public and 10% private) Institutions
    denoms
    1. counts
      1. group Id
        OG000
        value
        916
      units
      Participants
    title
    Baseline: Induction Treatment Performed
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        3
      title
      Public Institution
    2. measurements
      1. group Id
        OG000
        value
        14
      title
      Private Institution
    3. measurements
      1. group Id
        OG000
        value
        0
      title
      Both (90% public and 10% private) Institutions
    denoms
    1. counts
      1. group Id
        OG000
        value
        17
      units
      Participants
    title
    Baseline: Consolidation Treatment Performed
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        39
      title
      Public Institution
    2. measurements
      1. group Id
        OG000
        value
        32
      title
      Private Institution
    3. measurements
      1. group Id
        OG000
        value
        5
      title
      Both (90% public and 10% private) Institutions
    denoms
    1. counts
      1. group Id
        OG000
        value
        76
      units
      Participants
    title
    Baseline: Maintenance Treatment Performed
  4. categories
    1. measurements
      1. group Id
        OG000
        value
        230
      title
      Public Institution
    2. measurements
      1. group Id
        OG000
        value
        236
      title
      Private Institution
    3. measurements
      1. group Id
        OG000
        value
        29
      title
      Both (90% public and 10% private) Institutions
    denoms
    1. counts
      1. group Id
        OG000
        value
        495
      units
      Participants
    title
    2nd Line: Induction Treatment Performed
  5. categories
    1. measurements
      1. group Id
        OG000
        value
        22
      title
      Public Institution
    2. measurements
      1. group Id
        OG000
        value
        9
      title
      Private Institution
    3. measurements
      1. group Id
        OG000
        value
        4
      title
      Both (90% public and 10% private) Institutions
    denoms
    1. counts
      1. group Id
        OG000
        value
        35
      units
      Participants
    title
    2nd Line: Maintenance Treatment Performed
  6. categories
    1. measurements
      1. group Id
        OG000
        value
        7
      title
      Public Institution
    2. measurements
      1. group Id
        OG000
        value
        6
      title
      Private Institution
    3. measurements
      1. group Id
        OG000
        value
        1
      title
      Both (90% public and 10% private) Institutions
    denoms
    1. counts
      1. group Id
        OG000
        value
        14
      units
      Participants
    title
    2nd Line: Type of Treatment Performed After Transplantation
  7. categories
    1. measurements
      1. group Id
        OG000
        value
        142
      title
      Public Institution
    2. measurements
      1. group Id
        OG000
        value
        131
      title
      Private Institution
    3. measurements
      1. group Id
        OG000
        value
        11
      title
      Both (90% public and 10% private) Institutions
    denoms
    1. counts
      1. group Id
        OG000
        value
        284
      units
      Participants
    title
    3rd Line: Induction Treatment Performed
  8. categories
    1. measurements
      1. group Id
        OG000
        value
        13
      title
      Public Institution
    2. measurements
      1. group Id
        OG000
        value
        3
      title
      Private Institution
    3. measurements
      1. group Id
        OG000
        value
        2
      title
      Both (90% public and 10% private) Institutions
    denoms
    1. counts
      1. group Id
        OG000
        value
        18
      units
      Participants
    title
    3rd Line: Maintenance Treatment Performed
  9. categories
    1. measurements
      1. group Id
        OG000
        value
        2
      title
      Public Institution
    2. measurements
      1. group Id
        OG000
        value
        1
      title
      Private Institution
    3. measurements
      1. group Id
        OG000
        value
        0
      title
      Both (90% public and 10% private) Institutions
    denoms
    1. counts
      1. group Id
        OG000
        value
        3
      units
      Participants
    title
    3rd Line: Type of Treatment Performed After Transplantation
  10. categories
    1. measurements
      1. group Id
        OG000
        value
        70
      title
      Public Institution
    2. measurements
      1. group Id
        OG000
        value
        70
      title
      Private Institution
    3. measurements
      1. group Id
        OG000
        value
        6
      title
      Both (90% public and 10% private) Institutions
    denoms
    1. counts
      1. group Id
        OG000
        value
        146
      units
      Participants
    title
    4th Line: Induction Treatment Performed
  11. categories
    1. measurements
      1. group Id
        OG000
        value
        3
      title
      Public Institution
    2. measurements
      1. group Id
        OG000
        value
        2
      title
      Private Institution
    3. measurements
      1. group Id
        OG000
        value
        1
      title
      Both (90% public and 10% private) Institutions
    denoms
    1. counts
      1. group Id
        OG000
        value
        6
      units
      Participants
    title
    4th Line: Maintenance Treatment Performed
  12. categories
    1. measurements
      1. group Id
        OG000
        value
        0
      title
      Public Institution
    2. measurements
      1. group Id
        OG000
        value
        1
      title
      Private Institution
    3. measurements
      1. group Id
        OG000
        value
        0
      title
      Both (90% public and 10% private) Institutions
    denoms
    1. counts
      1. group Id
        OG000
        value
        1
      units
      Participants
    title
    4th Line: Type of Treatment Performed After Transplantation
denoms
  1. counts
    1. group Id
      OG000
      value
      922
    units
    Participants
description
Treatment patterns were collected from institutional charts \[included public institution, private institution and both (90% public and 10% private) institutions\] of participants in Brazil. The treatment patterns were collected as induction treatment, consolidation treatment, maintenance treatment performed at Baseline (at initial diagnosis) and as a induction treatment, maintenance treatment and type of treatment performed after transplantation, for second to tenth line of treatment. Only categories with data are reported. Participants were counted multiple times in different categories.
groups
  1. description
    Participants with MM were observed retrospectively since the diagnosis up to death or lost to follow-up within the eligibility window of time (between January 1, 2008 and December 31, 2016), in this study.
    id
    OG000
    title
    Multiple Myeloma Participants
param Type
COUNT_OF_PARTICIPANTS
population Description
All participants eligible for analyses were included. Number analyzed are the number of participants with evaluable data for given category.
reporting Status
POSTED
time Frame
From initial diagnosis up to end of follow up treatment or to the retrospective cut-off date within the time of interest (between January 1, 2008, and December 31, 2016) [approximately 11.7 years]
title
Number of Multiple Myeloma (MM) Participants Categorized by Treatment Patterns
type
PRIMARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice